These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18036072)

  • 1. The consensus development process in transfusion medicine: does it add value?
    Sher GD; Devine DV
    Transfusion; 2007 Dec; 47(12):2176-9. PubMed ID: 18036072
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathogen inactivation: making decisions about new technologies. Report of a consensus conference.
    Klein HG; Anderson D; Bernardi MJ; Cable R; Carey W; Hoch JS; Robitaille N; Sivilotti ML; Smaill F
    Transfusion; 2007 Dec; 47(12):2338-47. PubMed ID: 18036075
    [No Abstract]   [Full Text] [Related]  

  • 3. Pathogen inactivation: making decisions about new technologies - preliminary report of a consensus conference.
    Klein HG; Anderson D; Bernardi MJ; Cable R; Carey W; Hoch JS; Robitaille N; Sivilotti ML; Smaill F
    Vox Sang; 2007 Aug; 93(2):179-82. PubMed ID: 17683364
    [No Abstract]   [Full Text] [Related]  

  • 4. Holiday waistline. Time to consensus: the effect of the stomach on consensus decision-making at large conferences.
    Frank C; Macknight C
    CMAJ; 2006 Dec; 175(12):1569-71. PubMed ID: 17146097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recommendations for rationally-based hemotherapy].
    Welte M; Hachenberg T
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 Mar; 44(3):184-5. PubMed ID: 19266419
    [No Abstract]   [Full Text] [Related]  

  • 6. Health technology assessment in Europe.
    Kristensen FB
    Scand J Public Health; 2009 Jun; 37(4):335-9. PubMed ID: 19493989
    [No Abstract]   [Full Text] [Related]  

  • 7. International Association for Biologicals Symposium: "Advances in Transfusion Safety", Cambridge, UK. Foreword.
    Allain JP
    Biologicals; 2010 Jan; 38(1):1. PubMed ID: 20042348
    [No Abstract]   [Full Text] [Related]  

  • 8. [When new methods are about to be introduced].
    Graff BA; Thürmer H; Søreide O; Norderhaug IN
    Tidsskr Nor Laegeforen; 2008 Feb; 128(4):472. PubMed ID: 18274585
    [No Abstract]   [Full Text] [Related]  

  • 9. Health technology assessment in Scotland.
    Kohli HS
    Natl Med J India; 2003; 16(5):275-6. PubMed ID: 14680286
    [No Abstract]   [Full Text] [Related]  

  • 10. Transfusion medicine and proteomics. Alliance or coexistence?
    Thiele T; Steil L; Völker U; Greinacher A
    Blood Transfus; 2010 Jun; 8 Suppl 3(Suppl 3):s16-25. PubMed ID: 20606745
    [No Abstract]   [Full Text] [Related]  

  • 11. [Trends and new directions in transfusion medicine].
    Biscoping J; Götz E
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Oct; 33(10):661. PubMed ID: 9825051
    [No Abstract]   [Full Text] [Related]  

  • 12. Watch out! The electronic age in medicine is here.
    Ausman JI
    Surg Neurol; 2008 Aug; 70(2):221-2. PubMed ID: 18640403
    [No Abstract]   [Full Text] [Related]  

  • 13. [Consensus and non-consensus on portions of the blood transfusion policy].
    van Aken WG
    Ned Tijdschr Geneeskd; 1983 Oct; 127(40):1818-21. PubMed ID: 6633731
    [No Abstract]   [Full Text] [Related]  

  • 14. Final consensus statement of the Royal College of Physicians of Edinburgh Consensus Conference on Autologous Transfusion, 4-6 October 1995.
    Br J Haematol; 1996 Mar; 92(3):766. PubMed ID: 8616051
    [No Abstract]   [Full Text] [Related]  

  • 15. Blood transfusion administration-one- or two-person checks: which is the safest method?
    Watson D; Murdock J; Doree C; Murphy M; Roberts M; Blest A; Brunskill S
    Transfusion; 2008 Apr; 48(4):783-9. PubMed ID: 18194372
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical commentary: the transfusion trigger--the search for a quantitative holy grail.
    Myhre BA
    Ann Clin Lab Sci; 2001 Oct; 31(4):359-64. PubMed ID: 11688846
    [No Abstract]   [Full Text] [Related]  

  • 17. Guidelines for managing conscientious objection to blood transfusion.
    Ohto H; Yonemura Y; Takeda J; Inada E; Hanada R; Hayakawa S; Miyano T; Kai K; Iwashi W; Muto K; Asai F;
    Transfus Med Rev; 2009 Jul; 23(3):221-8. PubMed ID: 19539876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Criteria for evaluating consensus development conferences in medicine].
    Selbmann HK
    Fortschr Med; 1992 Jul; 110(20):377-8. PubMed ID: 1521842
    [No Abstract]   [Full Text] [Related]  

  • 19. Contribution of medical decision-making to consensus development conferences.
    Klazinga NS; Casparie AF; van Everdingen JJ
    Health Policy; 1987; 8(3):339-46. PubMed ID: 10285390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging DNA sequencing technologies for human genomic medicine.
    Strausberg RL; Levy S; Rogers YH
    Drug Discov Today; 2008 Jul; 13(13-14):569-77. PubMed ID: 18598911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.